De Novo Heterozygous KDM3B Variants Expand the Mutational Spectrum of Diets-Jongmans Syndrome: Case Series and Literature Review
Genes · 28.02.2026 · 17 (3) · 294
DOI: 10.3390/genes17030294 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, online erschienen am 28.02.2026. Verfasst von Haixia Miao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Metabolism, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children an…. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Growth Disorders, Intellectual Disability, Jumonji Domain-Containing Histone Demethylases. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xinwen Huang, “Pioneer” and “Leading Goose” R&D Program of Zhejiang Province.
Abstract (Originalsprache)
Background
Pathogenic variants in KDM3B have been implicated as the cause of Diets-Jongmans syndrome (DIJOS), an autosomal-dominant disorder characterized by growth retardation, intellectual disability, facial dysmorphism and autism-spectrum disorder. However, only a limited number of cases have been reported.
Methods
The general characteristics of four patients were recorded, including clinical features, child development, neuropsychological assessment and therapeutic interventions. Whole exome sequencing (WES) was performed for potential genetic causes and interpretation of variants was performed in accordance with ACMG guidelines.
Results
All patients carried de novo variants in the KDM3B gene, namely, c.2832-3C>G, c.1188del p.(Glu397Argfs*21), c.4580T>C p.(Leu1527Pro), and c.3220dup p.(Glu1074Glyfs*48). Unlike other patients with DIJOS who presented with growth retardation, mild to moderate intellectual developmental disorder and facial dysmorphism, our patients mainly presented with growth retardation, while their neurodevelopment was either normal or mildly impaired. In addition, our patients received primarily supportive care. One patient treated with recombinant human growth hormone (rhGH) showed improvement in growth.
Conclusions
Our results broaden the mutational spectrum of KDM3B-related disorder and highlight the inter-patient variability of the clinical phenotype. For the first time, we demonstrate that rhGH therapy can partially promote growth, providing novel evidence for genetic counseling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Metabolism, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents' Health and Disease, Hangzhou 310051, China.
Förderung
- Xinwen Huang
- “Pioneer” and “Leading Goose” R&D Program of Zhejiang Province
Zitieren
APA
Miao, H., Zhang, T., Chen, S., Xu, X., Fang, K., Wu, D., Zhang, Y., & Huang, X. (2026). De Novo Heterozygous KDM3B Variants Expand the Mutational Spectrum of Diets-Jongmans Syndrome: Case Series and Literature Review. Genes, 17(3), 294. https://doi.org/10.3390/genes17030294
Vancouver
Miao H, Zhang T, Chen S, Xu X, Fang K, Wu D, et al. De Novo Heterozygous KDM3B Variants Expand the Mutational Spectrum of Diets-Jongmans Syndrome: Case Series and Literature Review. Genes. 2026;17(3):294. doi:10.3390/genes17030294
BibTeX
@article{Miao2026,
author = {Miao, Haixia and Zhang, Ting and Chen, Shuai and Xu, Xiaocha and Fang, Kexin and Wu, Dingwen and Zhang, Yi and Huang, Xinwen},
title = {De Novo Heterozygous KDM3B Variants Expand the Mutational Spectrum of Diets-Jongmans Syndrome: Case Series and Literature Review},
journal = {Genes},
year = {2026},
volume = {17},
number = {3},
pages = {294},
doi = {10.3390/genes17030294}
}
EUVIMED